Results 1 to 10 of about 75 (74)

Apomorphine and psychopathology. [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1975
Forty men, mainly alcoholics, were administered either the dopamine receptor agonist, apomorphine HCl (1 mg), or distilled water subcutaneously three times a day for 14 days in a double blind study. None of the subjects developed an endogenous depression or schizophrenic symptoms.
Samarthji Lal, C E De la Vega
openaire   +2 more sources

Apomorphin und Psychostimulantiensucht [PDF]

open access: yesSUCHT, 2001
Apomorphin wurde Mitte des 19. Jahrhunderts ausgehend von Morphium hergestellt. Gleich nach der Synthese fiel dessen emetische Wirkung auf. Eine analgetische und euphorisierende Wirkung wie Morphium hatte es nicht. Klinisch ist es dann in hoheren Dosen bei Vergiftungen und spater auch zeitweise bei der Alkoholaversionstherapie verwendet worden ...
Delius, Juan   +2 more
openaire   +3 more sources

A study of tolerance to apomorphine [PDF]

open access: yesBritish Journal of Pharmacology, 1996
The present study was designed to investigate tolerance to several pharmacological effects of apomorphine. Changes in blood pressure, heart rate, plasma noradrenaline levels, rectal temperature, respiratory rate and retching plus vomiting were compared after administration of apomorphine (200 μg kg−1, i.v.
M. E. Llau   +5 more
openaire   +3 more sources

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

open access: yesProteins: Structure, Function, and Bioinformatics, EarlyView., 2023
Abstract Before the controversial approval of humanized monoclonal antibody lecanemab, which binds to the soluble amyloid‐β protofibrils, all the treatments available earlier, for Alzheimer's disease (AD) were symptomatic. The researchers are still struggling to find a breakthrough in AD therapeutic medicine, which is partially attributable to lack in ...
Sharif Arar   +2 more
wiley   +1 more source

Apomorphine [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1876
n ...
openaire   +2 more sources

Apomorphine in Epilepsy [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1878
n ...
openaire   +2 more sources

Motor Evoked Potentials Improve Targeting in Deep Brain Stimulation Surgery

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives One of the main challenges posed by the surgical deep brain stimulation (DBS) procedure is the successful targeting of the structures of interest and avoidance of side effects, especially in asleep surgery. Here, intraoperative motor evoked potentials (MEPs) might serve as tool to identify the pyramidal tract.
Petyo Nikolov   +7 more
wiley   +1 more source

Apomorphin in Eclampsia. [PDF]

open access: yesJournal of the American Medical Association, 1908
Hartshorn, Okla., May 4, 1908. To the Editor: —Dr. Morgan, in his article on "Treatment of Eclampsia" inThe Journal, May 2, 1908, makes no mention of apomorphin in that condition, and I do not remember ever having seen this drug mentioned in this connection.
openaire   +2 more sources

Apomorphine effects on the hippocampus

open access: yesNeural Regeneration Research, 2018
Apomorphine is a non-specific dopamine receptor agonist that has been used in the treatment of some diseases and mental disorders. Its use has particularly well documented in Parkinson's disease (PD). The dopaminergic agonists like apomorphine are related to oxidative processes that could induce cell damage and the functional impairment of some ...
Luis Enrique Arroyo-García   +2 more
openaire   +4 more sources

Reactionen Des Apomorphins [PDF]

open access: yesZeitschrift f�r Analytische Chemie, 1873
n ...
Quehl,, K�hler, H.
openaire   +3 more sources

Home - About - Disclaimer - Privacy